3SBio Inc. Announces Third Quarter 20... ( SHENYANG China Nov. 10 /Xinhua-- ...)

3SBio Inc. Announces Third Quarter 2008 Results

Date:11/10/2008

SHENYANG, China, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the third quarter ended September 30, 2008.

Third Quarter 2008 Financial Highlights:

-- Total net revenues increased 21.6% over the third quarter 2007 to

RMB68.2 million (US$10.0 million).

-- Net revenue from recombinant human erythropoietin ("EPO") products,

marketed under the EPIAO brand, increased 17.5% over the third quarter

2007 to RMB42.7 million (US$6.3 million).

-- Net revenue from protein-based therapeutic recombinant human

thrombopoietin ("TPO") products, marketed under the TPIAO brand

increased 39.3% over the third quarter 2007 to RMB19.7 million (US$2.9

million).

-- Operating income increased 21.4% over the third quarter 2007 to RMB20.7

million (US$3.1 million).

-- One-time impairment loss of approximately RMB19.1 million (US$2.8

million) for the third quarter 2008. This impairment loss was related

to a US$3.0 million aggregate principal amount of Floating Rate Notes,

which are linked to the credit of Lehman Brothers Holdings Inc. and

mature on January 21, 2009, subject to certain conditions.

-- Net income decreased 92.3% over the third quarter 2007 to RMB1.9

million (US$0.3 million).

-- Net income per American depositary share ("ADS") for the third quarter

2008 was RMB0.09 (US$0.01) compared with RMB1.11 (US$0.15) for the

third quarter 2007.

Nin
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Related biology technology :

1. 3SBio Inc. Files for SFDA Approval of NuLeusin
2. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
3. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
4. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
5. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
6. 3SBio Inc. Announces Results of Annual General Meeting
7. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. 3SBio Inc. to Hold Annual General Meeting
9. 3SBio Inc. Announces Second Quarter 2008 Results
10. 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
11. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference

Post Your Comments:

3SBio Inc. Announces Third Quarter 20...( SHENYANG China Nov. 10 /Xinhua-- ...)